Densely functionalised spirocyclic oxetane-piperidine scaffolds for drug discovery

被引：17
|
作者：
Geary, Gemma C. [1 ]
Nortcliffe, Andrew [1 ]
Pearce, Christopher A. [2 ]
Hamza, Daniel [2 ]
Jones, Geraint [2 ]
Moody, Christopher J. [1 ]
机构：
[1] Univ Nottingham, Sch Chem, Univ Pk, Nottingham NG7 2RD, England
[2] Sygnature Discovery Ltd, BioCity, Pennyfoot St, Nottingham NG1 1GF, England
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2018年 / 26卷 / 04期
关键词：
LEAD-ORIENTED SYNTHESIS; CHEMISTRY;
D O I：
10.1016/j.bmc.2017.12.012
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A spirocyclic, sp(3)-atom rich oxetane-containing scaffold was synthesised in just two steps via a gold catalysed propargylic alcohol rearrangement. The key gold cyclisation can be undertaken on a 40 g scale allowing the preparation of 419 lead-like compounds based on the scaffold for the European Lead Factory. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码：791 / 797
页数：7
相关论文
共 50 条
  • [21] "Angular" Spirocyclic Azetidines: Synthesis, Characterization, and Evaluation in Drug Discovery
    Kirichok, Alexander A.
    Tkachuk, Hennadii
    Levchenko, Kostiantyn
    Granat, Dmitry
    Yegorova, Tetyana
    Lesyk, Dmytro
    Anisiforova, Anna
    Holota, Yuliia
    Zomchak, Viktoriia
    Bodenchuk, Iryna
    Kosach, Viktoriia
    Borysko, Petro
    Korzh, Rodion A.
    Al-Maali, Galeb
    Kubyshkin, Vladimir
    Rzepa, Henry S.
    Mykhailiuk, Pavel K.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2025, 64 (07)
  • [22] Rapid access to novel multifunctional spirocyclic cores for drug discovery
    Moroz, Yurii
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [23] PHYTOCHEMICALS AS SCAFFOLDS FOR NEW DRUG SYNTHESIS AND DISCOVERY
    Sporn, Michael B.
    PHARMACEUTICAL BIOLOGY, 2012, 50 (05) : 611 - 611
  • [24] Assessing molecular scaffolds for CNS drug discovery
    Mayol-Llinas, Joan
    Nelson, Adam
    Farnaby, William
    Ayscough, Andrew
    DRUG DISCOVERY TODAY, 2017, 22 (07) : 965 - 969
  • [25] Privileged scaffolds and frequent hitters in drug discovery
    Schneider, Petra
    Schneider, Gisbert
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [26] Privileged scaffolds for library design and drug discovery
    Welsch, Matthew E.
    Snyder, Scott A.
    Stockwell, Brent R.
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2010, 14 (03) : 347 - 361
  • [27] Privileged Scaffolds in Natural Products and Drug Discovery
    Sun, Dianqing
    Guendisch, Daniela
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (11) : 1199 - 1199
  • [28] Polycyclic Sulfoximines as New Scaffolds for Drug Discovery
    Borst, Mark L. G.
    Ouairy, Cecile M. J.
    Fokkema, Sander C.
    Cecchi, Alessandro
    Kerckhoffs, Jessica M. C. A.
    de Boer, Vincent L.
    van den Boogaard, Peter J.
    Bus, Rutger F.
    Ebens, Rijko
    van der Hulst, Rob
    Knol, Joop
    Libbers, Rob
    Lion, Zhou M.
    Settels, Bart W.
    de Weyer, Ellen
    Attia, Khaled A.
    Sinnema, Piet-Jan
    de Gooijer, Jesse M.
    Harkema, Karen
    Hazewinkel, Marieke
    Snijder, Susan
    Pouwer, Kees
    ACS COMBINATORIAL SCIENCE, 2018, 20 (06) : 335 - 343
  • [29] Carbohydrate-based scaffolds in drug discovery
    Becker, Bernd
    Condie, Glenn C.
    Le, Giang Thanh
    Meutermans, Wirn
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2006, 6 (12) : 1299 - 1309
  • [30] Discovery of novel leukotriene A4 hydrolase inhibitors based on piperidine and piperazine scaffolds
    Sandanayaka, Vincent
    Mamat, Bjorn
    Bhagat, Nikhil
    Bedell, Louis
    Halldorsdottir, Gudrun
    Sigthorsdottir, Heida
    Andresson, Porkell
    Kiselyov, Alex
    Gurney, Mark
    Singh, Jasbir
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (09) : 2851 - 2854
12345